pubmed:abstractText |
Decreased levels of the cyclin-dependent kinase inhibitor p27(Kip1) in breast cancer are associated with a poor outcome. The prognostic significance of BRCA1/2 mutations is less clear, and the relationship between BRCA1/2 mutation status, p27(Kip1) protein levels, and outcome has not been studied.
|
pubmed:affiliation |
Department of Medicine, Sir M.B. Davis-Jewish General Hospital, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada.
|